EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Anti-inflammatory Mechanism of Alpinia purpurata (Vieill.) K. Schum. Rhizome Extract: Metabolite Profiling, Network Pharmacology, in vitro Safety, and in vivo Validation

Kiki Mulkiya Yuliawati iD, Fahriza Salsabilla Yuniar iD, Ellin Febrina iD, Gofarana Wilar iD, Raden Maya Febriyanti iD, Deshanda Kurniawan Prayoga iD, Faisal Kuswandani iD, Sri Adi Sumiwi iD, Supat Jiranusornkul, Jutti Levita iD

Iranian Journal of Pharmaceutical Research · 26.05.2026 · 25 (1)

DOI: 10.5812/ijpr-169725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 26.05.2026. Verfasst von Kiki Mulkiya Yuliawati und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alpinia purpurata has shown promising effects in alleviating inflammatory conditions; however, its underlying mechanisms require further investigation.

Objectives

This study aimed to elucidate the molecular mechanisms underlying the anti-inflammatory activity of A. purpurata rhizome extract (EEAP) and its active metabolites through the TLR4/MyD88 pathway.

Methods

The EEAP was analyzed for proximate composition, vitamin C content, total phenolic content (TPC), total flavonoid content (TFC), total monomeric anthocyanin content (TMAC), and metabolite profile, followed by a network pharmacology analysis. Cytotoxicity was evaluated in HEK-293 cells. An in vivo study of carrageenan-induced paw edema in rats was conducted to validate the findings.

Results

EEAP contained 42.12% ash, 34.66% moisture, 6.03% protein, 16.60% fat, and 0.59% carbohydrate. The vitamin C content was 941.55 mg/100 g extract, the TPC was 452.9 mg GAE/100 g extract, the TFC was 416.1 mg QUE/100 g extract, and the TMAC was 2770 mg/100 g extract. Functional enrichment analysis identified the TLR4/MyD88 signaling pathway as contributing to IL-23 production. Eight metabolites with anti-inflammatory properties were verified based on their Pa values: glycidyl oleate, 1-stearoylglycerol, alpha-linolenic acid, methyl palmitate, shogaol, 4-methoxybenzaldehyde, ginkgoneolic acid, and curcumene. EEAP was not toxic to HEK-293 cells (IC50= 741.1 μg/mL) compared with quercetin (IC50= 96.73 μg/mL) and cisplatin (IC50= 7.44 μg/mL). EEAP reduced edema volume but did not alter TLR4 or MyD88 expression under the present experimental conditions.

Conclusions

EEAP is not toxic to normal cells and exerts an anti-inflammatory effect by reducing edema volume in carrageenan-induced rats; however, it does not alter the TLR4/MyD88 pathway.

Schlagwörter

Stichwörter der Autor:innen

Alpinia SpeciesDrug DiscoveryInflammationQuercetinShogaolZingiberaceae

Autor:innen und Institutionen

  • Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.
  • Faculty of Mathematics and Natural Sciences, Bandung Islamic University, Bandung, Indonesia.
  • Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.
  • Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.
  • Department of Oral Biology, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia.
  • Department of Pharmaceutical Science, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Kiki Mulkiya Yuliawati, Fahriza Salsabilla Yuniar, Ellin Febrina, Gofarana Wilar, Raden Maya Febriyanti, Deshanda Kurniawan Prayoga, Faisal Kuswandani, Sri Adi Sumiwi, Jutti Levita

Zitieren

APA

Mulkiya Yuliawati, K., Salsabilla Yuniar, F., Febrina, E., Wilar, G., Febriyanti, R. M., Kurniawan Prayoga, D., Kuswandani, F., Adi Sumiwi, S., Jiranusornkul, S., & Levita, J. (2026). Investigating the Anti-inflammatory Mechanism of Alpinia purpurata (Vieill.) K. Schum. Rhizome Extract: Metabolite Profiling, Network Pharmacology, in vitro Safety, and in vivo Validation. Iranian Journal of Pharmaceutical Research, 25(1). https://doi.org/10.5812/ijpr-169725

Vancouver

Mulkiya Yuliawati K, Salsabilla Yuniar F, Febrina E, Wilar G, Febriyanti RM, Kurniawan Prayoga D, et al. Investigating the Anti-inflammatory Mechanism of Alpinia purpurata (Vieill.) K. Schum. Rhizome Extract: Metabolite Profiling, Network Pharmacology, in vitro Safety, and in vivo Validation. Iranian Journal of Pharmaceutical Research. 2026;25(1). doi:10.5812/ijpr-169725

BibTeX
@article{MulkiyaYuliawati2026,
  author = {Mulkiya Yuliawati, Kiki and Salsabilla Yuniar, Fahriza and Febrina, Ellin and Wilar, Gofarana and Febriyanti, Raden Maya and Kurniawan Prayoga, Deshanda and Kuswandani, Faisal and Adi Sumiwi, Sri and Jiranusornkul, Supat and Levita, Jutti},
  title = {Investigating the Anti-inflammatory Mechanism of Alpinia purpurata (Vieill.) K. Schum. Rhizome Extract: Metabolite Profiling, Network Pharmacology, in vitro Safety, and in vivo Validation},
  journal = {Iranian Journal of Pharmaceutical Research},
  year = {2026},
  volume = {25},
  number = {1},
  doi = {10.5812/ijpr-169725}
}
Kostenlos starten →